Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06639386 · ClinicalTrials.gov registry record
Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups
A clinical trial of Vaccine Hesitancy and Vaccine Refusal, sponsored by Boston Medical Center.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT06639386: Recruiting study of Vaccine Hesitancy and Vaccine Refusal, sponsored by Boston Medical Center.
NCT06639386 is a study of Vaccine Hesitancy and Vaccine Refusal that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 80 participants, below the 1,304-participant average among 5 other Vaccine Hesitancy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06639386, a study of Vaccine Hesitancy and Vaccine Refusal, is actively recruiting participants, sponsored by Boston Medical Center.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Achieving optimal vaccination rates is vital for protecting the health and well-being of all individuals. This specific study focuses on the MMR and RSV vaccines in pregnancy and early childhood, which have been shown to reduce RSV and MMR-related illnesses, hospitalizations, and deaths. Efforts to improve vaccination rates have not been equally effective across the entire population; this has resulted in poorer outcomes from interventions for certain populations who are vaccine-hesitant. This study seeks to understand how to best increase vaccine confidence in marginalized populations. To do this, the investigators will interview parents of children who receive care at Boston Medical Center (BMC), Community Health Workers and other Clinical providers at BMC, leading experts in the fields of vaccine confidence and implementation science, and key public health stakeholders/officials.
Primary Outcome
Interviews will be conducted with parents and themes will be abstracted that relate to vaccine confidence. Counts of participants for each theme will be reported.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-01-31 |
| Est. Completion | 2026-03 |
What NCT06639386 shows while recruiting
NCT06639386 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,304-participant average among 5 other Vaccine Hesitancy trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Vaccine Hesitancy appearing as the primary indexed condition, and to 0 interventions.
NCT06639386 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06639386 about?
NCT06639386 is a clinical study titled "Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups". Achieving optimal vaccination rates is vital for protecting the health and well-being of all individuals. This specific study focuses on the MMR and RSV vaccines in pregnancy and early childhood, which have been shown to reduce RSV and MMR-related illnesses, hospitalizations, and deaths. Efforts to ...
What is the current status of trial NCT06639386?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2025-01-31. Estimated completion is 2026-03.
What conditions does trial NCT06639386 study?
This clinical trial studies the following conditions: Vaccine Hesitancy, Vaccine Refusal.
Who is sponsoring clinical trial NCT06639386?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06639386 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaccine Hesitancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support
RECRUITING · NA
-
Communication Strategies to Increase HPV Vaccination Intention
RECRUITING · NA
-
RADx-UP Phase 3D (Oregon Saludable: Juntos Podemos)
ACTIVE NOT RECRUITING · NA
-
Vaccine Hesitancy: A Survey of Pediatric Clinicians
COMPLETED
-
COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI